Radiopharm Theranostics Limited Sponsored ADR's market cap is currently $56.98M. The company's EPS TTM is $-1.961; its P/E ratio is ―; Radiopharm Theranostics Limited Sponsored ADR is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is $-1.62. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in AUD
Radiopharm Theranostics Limited Sponsored ADR Earnings and Revenue History
